Award
National Institute on Aging 5R41AG085916-02
Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD
Recipient
Not specified
Award Amount
$222,594.00
Ceiling
$222,594.00
Awarded
January 24, 2025
Identifier
5R41AG085916-02
Research grant awarded by the National Institute on Aging to develop a growth hormone receptor antagonist to delay or prevent Alzheimer's disease and related dementias, with a project duration from February 2024 to January 2027 and an award amount of approximately $222,594.
Description
This is a research grant opportunity from the NIH for developing a growth hormone receptor antagonist aimed at delaying or preventing Alzheimer's disease and related dementias. The project involves optimizing production, assessing pharmacokinetics and pharmacodynamics, and testing efficacy in rodent models.